Sarcopenia and blood myokine levels as prognostic biomarkers in patients with liver cirrhosis or hepatocellular carcinoma
Sooyeon Oh, Jooho Lee
Clin Mol Hepatol. 2020;26(4):476-479.   Published online 2020 Oct 1     DOI:
Citations to this article as recorded by Crossref logo
Regulator 1-Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α Signaling Pathway in Investigating the Pathological Characteristics and Molecular Mechanism of Liver Cirrhosis Complicated by Acute Kidney Injury
Jieqi Gong, Huanhua Lu
Journal of Biomaterials and Tissue Engineering.2022; 12(1): 112.     CrossRef
Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis
Ji Won Han, Da In Kim, Hee Chul Nam, U Im Chang, Jin Mo Yang, Do Seon Song
Clinical and Molecular Hepatology.2022; 28(2): 219.     CrossRef
Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis
Takumi Kawaguchi, Takuji Torimura
Clinical and Molecular Hepatology.2022; 28(2): 177.     CrossRef
Association of Physical Activity with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
Ho Soo Chun, Sojeong Park, Minjong Lee, Yuri Cho, Ha Sung Kim, A Reum Choe, Hwi Young Kim, Kwon Yoo, Tae Hun Kim
Cancers.2021; 13(14): 3424.     CrossRef